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S U M M A R Y
Objective: Community-genotype methicillin-resistant Staphylococcus aureus (CG-MRSA) isolates are
known to be more virulent and clinically aggressive in children. The goal of the present study was
characterize the molecular epidemiology of MRSA isolates causing infections in Colombian children.
Methods: An observational and prospective study was conducted between April 2009 and June 2011 at
15 hospitals in Bogota´, Colombia. A detailed epidemiological proﬁle was made of 162 children infected
with MRSA. The isolates were subjected to antimicrobial susceptibility testing, molecular characteriza-
tion including 21 virulence genes, SCCmec, spa and agr typing, multilocus sequence typing (MLST), and
pulsed-ﬁeld gel electrophoresis (PFGE).
Results: Among all isolates included in the study, 85.8% were obtained from patients whose infectious
process was initiated in the community; of these, 69,8% occurred in patients without healthcare-
associated risk factors. The molecular characterization of the isolates showed a high proportion (95.1%)
containing a community-genotype proﬁle with a high prevalence of SCCmec type IV, PVL-positives, and
also related to CC8. Most CG-MRSA isolates (143, 92.9%) were genetically related to the pandemic clone
USA300, differing by the presence of SCCmec IVc and the absence of the arginine catabolic mobile
element (ACME).
Conclusions: An increase in the frequency of CG-MRSA infections has been reported worldwide. In this
study we found that almost all MRSA infections in our pediatric population were caused by community-
genotype isolates, supporting the success of the CG-MRSA clones.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has become
a signiﬁcant cause of community- and healthcare-associated
infections. It is possible to genetically and molecularly differentiate
between MRSA isolates associated with the community environ-
ment (community-genotype, CG) and those associated with the* Corresponding author. Tel.: +57 1 6331368.
E-mail address: labgenmolecular@unbosque.edu.co (J.A. Escobar Pe´rez).
http://dx.doi.org/10.1016/j.ijid.2014.01.008
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).hospital environment (hospital-genotype, HG).1 CG-MRSA isolates
have been considered more virulent than HG-MRSA, possibly due
to the acquisition or overexpression of factors such as Panton–
Valentine leukocidin (PVL) and phenol-soluble modulins.2,3
USA300 is the most widespread CG-MRSA clone on the American
continent, although it has also been described in Europe, Asia, and
Oceania.4,5 In the past decade, an increase in both invasive and
non-invasive infections in children caused mainly by this clone has
been documented, reaching epidemic proportions.6,7
Since 2006, the spread of a CG-MRSA clone (ST8-IVc-PVL+)
genetically related to the USA300 clone has been described inciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Comparison of the genetic backgrounds of MRSA from infected children in Bogota´,
Colombia
Characteristics of isolates CG-MRSA, n (%) HG-MRSA, n (%)
n = 154 n = 8
Clonal complex CC5 1 (0.6) 7 (87.5)
CC8 152 (98.7) 0
ND 1 (0.6) 1 (12.5)
agr group I 152 (98.7) 1 (12.5)
II 0 7 (87.5)
III 2 (1.3) 0
SCCmec type I 0 6 (75.0)
II 0 1 (12.5)
IVa 11 (7.1) 0
IVb 1 (0.6) 0
IVc 139 (90.3) 0
IVh 3 (1.9) 0
NT 0 1 (12.5)
Toxin gene seq 121 (78.6) 0
sek 113 (73.4) 0
eta 92 (59.7) 4 (50.0)
sej 16 (10.4) 0
sel 15 (9.7) 1 (12.5)
seg 12 (7.8) 3 (37.5)
hlg 10 (6.5) 2 (25.0)
seh 11 (7.1) 3 (37.5)
sea 8 (5.2) 1 (12.5)
see 3 (1.9) 1 (12.5)
seo 1 (0.6) 8 (100)
sem 1 (0.6) 8 (100)
sec 1 (0.6) 4 (50.0)
seb 1 (0.6) 0
sei 0 6 (75.0)
sen 0 5 (62.5)
etb 0 1 (12.5)
Other virulence factor genes lukS/F-PV 153 (98.7) 0
bsaB 150 (97.4) 0
MRSA, methicillin-resistant Staphylococcus aureus; CG, community-genotype; HG,
hospital-genotype; ND, not determined; NT, non-typeable.
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reported three circulating cases of this clone among Colombian
children.10 Despite recent reports in the Colombian pediatric
population,11,12 information about the molecular characterization
of MRSA infections in this population is still limited in our region.
Therefore, we performed the molecular characterization of MRSA
isolates from pediatric patients with infections treated in 15
separate healthcare institutions in Bogota´, Colombia.
2. Methods
2.1. Study setting
From April 2009 to June 2011, we conducted a prospective
study of MRSA infections in pediatric patients from 15 tertiary-
level hospitals in Bogota´, which is the largest city in Colombia. The
medical records were reviewed to differentiate colonization from
true infection in the case of isolates from non-sterile sites like skin
(in the absence of clinical signiﬁcance), catheters, or sputum.
Subsequently, only true infections were included in the study.
Informed consent was obtained and the study was approved by the
institutional review boards of the participating hospitals.
2.2. Genetic and molecular characterization of isolates
The SCCmec type and subtype were established as described
previously.13 SCCmec IVc was conﬁrmed by differential ampliﬁca-
tion between IVc and IVE cassettes at speciﬁc DNA fragments in the
J3 region. The presence of the genes lukS/F-PV, sausa400, bsaB, etb,
eta, hlg, sea, seb, sec, seg, seh, sei, sej, sek, sel, sem, sen, seo, seq, arcC, and
opp (the ﬁnal two as markers of the arginine catabolic mobile
element, ACME) were also determined, as described previously.14,15
2.3. Determination of the genetic relationship between isolates by
restriction of housekeeping genes, multilocus sequence typing (MLST),
pulsed-ﬁeld gel electrophoresis (PFGE), agr and spa typing
The relationship of the isolates to clonal complex (CC) 5 or 8 was
established by analysis of mutations in the arcC and gmk genes.16
The agr group was determined as reported previously.17 The
genetic relationship between isolates was determined by PFGE.
The pulsotypes were interpreted according to the percentage
similarity and the criteria proposed by Tenover et al.18 GelCompar
II program (Applied Maths NV) was used, with a tolerance position
of 1.5% and Dice coefﬁcient of 1.0%. MLST and the spa type were
determined for representative isolates of the main pulsotypes, as
reported previously.19,20
2.4. Genotypic classiﬁcation of isolates
MRSA isolates were classiﬁed according to their genetic
characteristics (genotype), taking into account previous results in
our region,21 including molecular background and the PFGE
pulsotype, as follows. Isolates with SCCmec type IV (subtype a, b,
c, or h) and any of the following characteristics were considered
community-genotype (CG-MRSA): the presence of genes lukS/F-PV,
seq, sek, or bsaB and/or PFGE pulsotype related to the USA300 clone.1
Isolates with SCCmec I or II, the presence of the sem and seo genes,
and/or a PFGE pulsotype related to the Cordobe´s/Chilean or
pediatric clones were considered hospital-genotype (HG-MRSA).1,22
2.5. Microbiological characterization of isolates
The susceptibility proﬁle to 11 antibiotics and inducible
clindamycin resistance were determined by agar dilution method
and the D-test, respectively, as recommended by the Clinical andLaboratory Standards Institute.23 Isolates found to be non-
susceptible or resistant to three or more antimicrobial categories
were classiﬁed as multidrug-resistant.24
2.6. Epidemiological and clinical classiﬁcation of infections
Community-acquired MRSA (CA-MRSA) infections were classi-
ﬁed as those that were detected within the ﬁrst 48 h of hospital
admission, without healthcare-associated risk factors (HARF),25,26
and hospital-acquired MRSA (HA-MRSA) infections were classiﬁed
as those detected after the ﬁrst 48 h of hospital admission.25
Furthermore, community-onset MRSA infections were classiﬁed to
be healthcare-associated MRSA (HCA-MRSA) infections based on
the presence of healthcare-associated risk factors (HARF).
3. Results
3.1. Genetic and molecular characteristics of MRSA isolates
During the study period, 162 MRSA isolates were collected from
pediatric infections (one isolate per patient), of which 154 (95.1%)
were SCCmec type IV, six (3.7%) were type I, one (0.6%) was type II,
and one (0.6%) was non-typeable. agr I was the most frequent
group (94.4%), followed by agr II (4.3%) and agr III (1.2%).
Restriction analysis of housekeeping genes showed 152 (93.8%)
isolates to be related to CC8 and eight (4.9%) to CC5; the other two
(4.9%) isolates could not be typed by this method. According to the
results of the molecular analyses, 154 (95.1%) isolates were
classiﬁed as CG-MRSA22 and the remaining eight (4.9%) were
classiﬁed as HG-MRSA.
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and the bsaB, seq, and sek genes were detected in 150 (97.4%), 121
(78.6%), and 113 (73.4%) isolates, respectively. In this group, 139
isolates (90.3%) were SCCmec IVc, 11 (7.1%) IVa, three (1.9%) IVh,
and one (0.6%) IVb subtypes. Only two of the CG-MRSA isolates
(1.3%) were agr group III, and the remaining 152 (98.7%) were agr
group I (Table 1). ACME was not found in any isolate.Figure 1. Genetic relationship by PFGE of MRSA isolates from pediatric patients. Isolates
Maths NV) was used, with a tolerance position of 1.5% and Dice coefﬁcient of 1.0%. PFGE p
presence of pathogenicity island 5 (SaPI5) was conﬁrmed by ampliﬁcation of the sausa30
determined; NR= not reported spa type number (for Cordobe´s/Chilean clone and 5sau
respectively); CG-NR = isolated community-genotype MRSA with pulsotype not related
related to Cordobe´s/Chilean clone.PFGE analysis revealed that, of the 154 CG-MRSA isolates, 143
(92.9%) were genetically related to the USA300 clone (<6 bands of
difference and a similarity >83%) (Figure 1). The U1 pulsotype was
the most common and was found in 91 isolates (56.2%) (Table 2).
The most frequent enterotoxin proﬁle was seq–sek, which was
detected in 113 isolates (73.4%), although other enterotoxin
proﬁles were found to a lesser extent. The eta gene was detected representative of the main pulsotypes are shown. GelCompar II program (Applied
atterns were considered different when they showed a similarity less than 80%. The
0_0808 gene and speciﬁc fragments at the insertion site. NT = not typeable; ND = not
314 isolate the repeats in spa typing were TIMEMDMGMGMK and A2DKBEMBB,
 to USA300 clone; HG-NR = isolated hospital-genotype MRSA with pulsotype not
Table 2
Molecular classiﬁcation and antimicrobial susceptibility of MRSA isolated from infected children
Characteristics of isolates All subjects (N = 162) CO-MRSA (n = 139) HA-MRSA (n = 23)
CA (n = 97) HCA (n = 42)
Type of isolate
CG-MRSA 154 (95.1) 97 (100) 41 (97.6) 16 (69.6)
HG-MRSA 8 (4.9) 0 1 (2.4) 7 (30.4)
Pulsed-ﬁeld pulsotypea,b
U1 91 (56.2) 54 (55.7) 27 (64.3) 10 (43.5)
U2 16 (9.9) 12 (12.4) 3 (7.1) 1 (4.3)
U3 12 (7.4) 7 (7.2) 4 (9.5) 1 (4.3)
U4 8 (4.9) 6 (6.2) 0 2 (8.7)
U5 7 (4.3) 5 (5.2) 1 (2.4) 1 (4.3)
U6 4 (2.5) 2 (2.1) 2 (4.8) 0
U7 4 (2.5) 3 (3.1) 1 (2.4) 0
U8 2 (1.2) 1 (1.0) 1 (2.4) 0
U9 to U15 7 (4.3) 5 (5.2) 2 (4.8) 0
CG-NR 3 (1.9) 2 (2.1) 0 1 (4.3)
F 6 (3.7) 0 1 (2.4) 5 (21.7)
HG-NR 2 (1.2) 0 0 2 (8.7)
Antimicrobial susceptibility proﬁle
OXA 84 (51.9) 54 (55.7) 20 (47.6) 10 (43.4)
OXA, TET 53 (32.7) 29 (29.9) 16 (38.1) 8 (34.8)
OXA, ERY 8 (4.9) 5 (5.2) 3 (7.1) 0
OXA, ERY, TET 6 (3.7) 6 (6.2) 0 0
OXA, GEN, CIP, ERY, CLI 4 (2.5) 0 1 (2.4) 3 (13.0)
OXA, GEN, CIP, ERY, TET, CLI 2 (1.2) 1 (1.0) 0 1 (4.4)
OXA, GEN, CIP, TET, CLI 1 (0.6) 0 0 1 (4.4)
OXA, GEN, ERY, CLI 1 (0.6) 0 1 (2.4) 0
OXA, GEN, ERY, TET 1 (0.6) 1 (1.0) 0 0
OXA, GEN 1 (0.6) 1 (1.0) 0 0
OXA, TET, CLI 1 (0.6) 0 1 (2.4) 0
MRSA, methicillin-resistant Staphylococcus aureus; CO-MRSA, community-onset MRSA infection; CA, community-acquired; HCA, healthcare-associated; HA-MRSA, hospital-
acquired MRSA infection; CG-MRSA, community-genotype MRSA; HG-MRSA, hospital-genotype MRSA; OXA, oxacillin; TET, tetracycline; ERY, erythromycin; GEN,
gentamicin; CIP, ciproﬂoxacin; CLI, clindamycin.
a The pulsotypes related to USA300 were appointed as U and the pulsotypes related to Cordobe´s/Chilean clone were appointed as F.
b CG-NR = isolated CG-MRSA with pulsotype not related to USA300 clone; HG-NR = isolated HG-MRSA with pulsotype not related to Cordobe´s/Chilean clone.
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isolates were related to CC8 (98.7%), and ﬁve representative
isolates of the main pulsotypes belonged to sequence type (ST) 8.
The spa type was determined for 20 isolates (selected from the
main PFGE pulsotypes; Figure 1). Of these, seven selected isolates
of pulsotypes U1, U2, U3, U4, and U6 were spa type t008 and four
isolates with pulsotype U5 were spa type t024. Among the 11 CG-
MRSA isolates not related to USA300 (CG-NR), the spa types found
were: t024, t1814, and t1635 in one, one, and nine isolates,
respectively. The spa type t1635 was found in eight isolates that
belonged to a new emergent clone.22
Molecular characterization of the eight HG-MRSA isolates
revealed that six isolates (75.0%) were SCCmec type I, one (12.5%)
was type II, and one (12.5%) was non-typeable. All eight isolates
had sem and seo genes, seven were agr group II and one was agr
group I. Seven (87.5%) isolates were related to CC5; the clonal
complex of the remaining isolate was not determined (Table 2).
The restriction and PFGE analyses showed that ﬁve (62.5%) isolates
were genetically related to the Cordobe´s/Chilean clone and the
three remaining isolates (37.5%) produced pulsotypes unrelated to
the Cordobe´s/Chilean, Pediatric, Brazilian, or New York/Japan
clones, which frequently circulate in South American hospitals
(Table 2). A representative isolate of pulsotype F harbored spa type
t149 (TO2MEMDMGMGMK) related to that of the Cordobe´s/
Chilean clone (TIMEMDMGMGMK).
3.2. Microbiological characteristics of MRSA isolates
Although most of the CG-MRSA isolates (83, 53.9%) were only
resistant to oxacillin (not resistant to non-b-lactam antibiotics),
resistance to tetracycline, erythromycin, gentamicin, clindamycin,and ciproﬂoxacin was also found in 61 (39.6%), 17 (11.0%), four
(2.6%), three (1.9%), and one (0.6%) isolates, respectively. Resis-
tance to trimethoprim–sulfamethoxazole, vancomycin, linezolid,
chloramphenicol, and rifampin was not found. Three CG-MRSA
isolates (1.9%) were multidrug-resistant (resistant to more than
three antibiotics). Of the 16 (10.4%) CG-MRSA isolates resistant to
erythromycin, 11 (7.1%), three (1.9%), and two (1.2%) had M,
constitutive, and inducible MLSB phenotype, respectively. Six
(75.0%) of the eight HG-MRSA isolates were multidrug-resistant.
3.3. Clinical and epidemiological classiﬁcation
It was found that of the 162 patients included in the study,
infection had initiated in the community (with or without HARF) in
139 of the patients (85.8%) and infection had initiated in the
hospital (HA-MRSA) in 23 of the patients (14.2%). Among
community-onset MRSA infections, 97 (69.7%) occurred in patients
69,8% who had no HARF (CA-MRSA) and 42 (30.2%) were associated
with healthcare (HCA-MRSA). According to the molecular classiﬁ-
cation, 97 (100%) CA-MRSA, 41 (97.6%) HCA-MRSA, and 16 (69.6%)
HA-MRSA infections were caused by CG-MRSA isolates (Table 2).
4. Discussion
In Colombia, the ﬁrst two cases of CG-MRSA infection in adult
patients were reported in 2006,8 and in 2009, the circulation of this
USA300 variant (ST8-MRSA-IVc-PVL+-ACME-negative) was found
in 31% of adult patients.9 Likewise, in 2010, we reported that 26.4%
of MRSA infections in Colombian adults were caused by CG-
MRSA.27 The ﬁndings from US hospitals suggest similar frequen-
cies among CG- and HG-MRSA isolates in adult patients;1,28 in
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MRSA.29 However, our results showed that almost all infections in
the Colombian pediatric population were generated by CG-MRSA
isolates. These results show that MRSA infections in children are
quite different in our country. This may be due to an improved
competitive advantage for the CG-MRSA USA300-related clone in
this population.
The signiﬁcance of PVL and ACME in the increased virulence and
pathogenicity of USA300 is controversial. Kreisel et al. found that
97% of USA300 isolates causing bacteremia in adult patients had
PVL and suggested its role as a virulence factor.30 In the case of
infections in our pediatric population, the almost ubiquitous
presence of PVL in CG-MRSA isolates could favor its successful
spread, although it would be necessary to conduct further studies
to clarify the determinants of this high proportion.
In contrast to the USA300 clone circulating in the USA, the CG-
MRSA clones circulating in our region harbor SCCmec type IVc
(3.1.2) and do not carry ACME. It was previously believed that
ACME was contributing to the ease of spread of USA300 by skin
contact.31 However, ACME-negative USA300 strains are frequently
found in Australia, Colombia, and other South American coun-
tries.8,9,27,31 Although Australian isolates differ by the presence of
the mer operon at this position, we did not ﬁnd DNA insertions
upstream or downstream of SCCmec in the Colombian strains (data
not shown).
In a study of the epidemiological distribution of ACME in S.
aureus with pulsotypes closely related to the USA300 clone, all
SCCmec type IVa isolates were found to carry ACME, in contrast to
isolates with SCCmec IVc or IVb, or in non-typeable isolates in
which ACME was not detected.32 These results are in agreement
with our current results. However, in our case, ACME was also not
detected in the isolates with SCCmec IVa. It is possible that the
Colombian isolates possess another type of gene or mobile genetic
element that compensates for the absence of ACME. Therefore,
further analysis to determine differences in our isolates would be
enlightening.
The microbiological analyses showed that a high percentage of
isolates were susceptible to most non-b-lactam antibiotics, a
result that is in agreement with the previous reports for CG-MRSA
isolates. However, these isolates were also detected in high
proportions in hospital infections and in patients with HARF, who
are frequently treated with antibiotics, which generates the danger
of the emergence of multiple resistance in strains with community
genotypes that are usually more virulent.
The high frequency of CG-MRSA infections in children in the
Colombian pediatric population in community and hospital
settings should be noted. Furthermore, molecular analyses
revealed genetic differences between clones related to the
USA300 strains circulating in Colombia and those circulating in
the USA and elsewhere in the world, raising new questions about
the features that are shared or that differentiate these clones
contributing to their successful propagation.
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